{"id":389960,"date":"2023-12-20T19:00:00","date_gmt":"2023-12-21T00:00:00","guid":{"rendered":"https:\/\/platohealth.ai\/coopercompanies-to-present-at-the-j-p-morgan-42nd-annual-healthcare-conference-biospace\/"},"modified":"2023-12-22T09:29:42","modified_gmt":"2023-12-22T14:29:42","slug":"coopercompanies-to-present-at-the-j-p-morgan-42nd-annual-healthcare-conference-biospace","status":"publish","type":"post","link":"https:\/\/platohealth.ai\/coopercompanies-to-present-at-the-j-p-morgan-42nd-annual-healthcare-conference-biospace\/","title":{"rendered":"CooperCompanies to Present at the J.P. Morgan 42nd Annual Healthcare Conference | BioSpace","gt_translate_keys":[{"key":"rendered","format":"text"}]},"content":{"rendered":"

SAN RAMON, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) — CooperCompanies<\/a><\/strong> (Nasdaq: COO), a leading global medical device company, will participate at the J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024. Al White, President and CEO, will represent the Company in a session scheduled to begin at 6:00 PM ET.<\/p>\n

The webcast will be available to investors and other interested parties by accessing the CooperCompanies\u2019 website at http:\/\/investor.coopercos.com<\/a>. A replay of the event will be available on the same webpage following its conclusion.<\/p>\n

About CooperCompanies<\/strong><\/p>\n

CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on improving lives one person at a time. The Company operates through two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, improving the vision of millions of people every day. CooperSurgical is a leading fertility and women\u2019s health company dedicated to assisting women, babies and families at the healthcare moments that matter most. Headquartered in San Ramon, CA, CooperCompanies (\u201cCooper\u201d) has a workforce of more than 15,000 with products sold in over 130 countries. For more information, please visit www.coopercos.com<\/a>.<\/p>\n

Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com<\/a><\/p>\n


<\/p>\n

\"Primary<\/a><\/p>\n